Lung Neoplasms
Showing 51 - 75 of >10,000
Lung Cancer Screening Trial (Educational Video about LDCT lung cancer screening, A culturally tailored shared decision-making
Not yet recruiting
- Lung Cancer Screening
- Educational Video about LDCT lung cancer screening
- +3 more
- (no location specified)
Jun 17, 2023
The Alterations of Metabolic Adipo-myokines and Body Composition
Recruiting
- Lung Cancer Metastatic
-
Kaohsiung City, TaiwanKaohsiung Chang Gung Memorial Hospital
Sep 24, 2023
Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer (ES-SCLC)
- (no location specified)
Sep 19, 2023
Extensive Stage Small Cell Lung Cancer
Not yet recruiting
- Extensive-stage Small-cell Lung Cancer
-
Changsha, Hunan, ChinaHunan Cancer hospital
Aug 6, 2023
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Lung Cancer ID (Identity) Study
Not yet recruiting
- Lung Cancer Stage IV
- Advanced lung cancer patients' group
-
Roma, Italy
- +1 more
Oct 4, 2023
Radio-induced Toxicities in Treatment of Lung Cancer With
Not yet recruiting
- Lung Cancer
-
Metz, FranceCHR Metz-Thionville/Hopital de Mercy
Jun 5, 2023
NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Non-small Cell Lung Cancer
- +2 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 27, 2023
Lung Cancer Trial in Copenhagen (Resistance training)
Not yet recruiting
- Lung Cancer
- Resistance training
-
Copenhagen, DenmarkUniversity Hospital of Copenhagen
Mar 17, 2023
NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)
Not yet recruiting
- Non-small Cell Lung Cancer
- +2 more
- Nintedanib, gefitinib, erlotinib, afatinib
- (no location specified)
Oct 2, 2023
Lung Cancer, NSCLC, Brain Metastases Trial (Alectinib, Stereotactic Radiosurgery)
Not yet recruiting
- Lung Cancer
- +2 more
- Alectinib
- Stereotactic Radiosurgery
- (no location specified)
Aug 4, 2023
Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)
Not yet recruiting
- Stage II-IIIB(N2) Non-small Cell Lung Cancer
- TQB2450
- +4 more
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Oct 26, 2023
Epicardial Adipose Tissue for Pulmonary Embolism and Death in
Not yet recruiting
- Pulmonary Embolism
- Lung Cancer
- CTPA (computed tomography pulmonary angiography)
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
Aug 24, 2023
Lung Cancer Trial in Kayseri (Pranayama breathing exercise)
Recruiting
- Lung Cancer
- Pranayama breathing exercise
-
Kayseri, Talas, TurkeyErciyes University
Aug 10, 2023
Lung Cancer Trial (exercise)
Not yet recruiting
- Lung Cancer
- exercise
- (no location specified)
Jul 17, 2023
Lung Cancer, Lung Cancer Screening Trial in Seattle (Stepped Reminders, Patient Education)
Enrolling by invitation
- Lung Cancer
- Lung Cancer Screening
- Stepped Reminders
- Patient Education
-
Seattle, WashingtonKaiser Permanente
Feb 17, 2023
Lung Nodules Detected During Lung Cancer Screening
Not yet recruiting
- Lung Cancer
- Lung MRI
- Blood Draw
- (no location specified)
Jan 22, 2023
Family Members and Peers of Lung Cancer Patients:Prospective
Not yet recruiting
- Lung Cancer
- +2 more
- (no location specified)
Dec 14, 2022
Participation for Small Cell Lung Cancer Patients
Not yet recruiting
- Small Cell Lung Cancer
- (no location specified)
Mar 3, 2023
Lung Cancer Trial (Healthy lung sparing treatment plan)
Not yet recruiting
- Lung Cancer
- Healthy lung sparing treatment plan
- (no location specified)
Nov 7, 2023
Biomarkers in Lung Cancer
Not yet recruiting
- Lung Nodule
- Lung Cancer
- Extra blood sampling, Non-invasive or leftover samples or medical waste
-
Toulouse, FranceLarrey Hospital
Sep 19, 2023
Elderly Patients, Metastatic Lung Cancer Trial in Wuhan (Single drug chemo plus immunotherapy)
Not yet recruiting
- Elderly Patients
- Metastatic Lung Cancer
- Single drug chemotherapy plus immunotherapy
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Sep 15, 2023